Capital Flow Monitor · Sponsors · CIK 1474720
Neuros Medical, Inc.
26800 Aliso Viejo Pkwy, Suite 250, Aliso Viejo, CA, 92656 · 440-951-2565
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$65.0M
Sold
$56.0M
% sold
86.2%
Investors
28
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-06 | D ·current | 506(b) | $65.0M | $56.0M | 86.2% | 28 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- David Veino — Executive Officer / Director, Aliso Viejo, CA
- Zach Stassen — Executive Officer, Aliso Viejo, CA
- William Harrington — Director, Aliso Viejo, CA
-
Marc-Andre Marcotte — Director, Aliso Viejo, CA
3 other raises
- Cagent Vascular, Inc. $24.5M of $41.0M · 59.7%
- Miach Orthopaedics Inc. $7.5M of $15.0M · 50.0%
- Iantrek, Inc. $34.7M of $42.0M · 82.8%
-
Casey Tansey — Director, Aliso Viejo, CA
3 other raises
- U.S. Venture Partners XIV, L.P. $0 of $400.0M · 0.0%
- Cagent Vascular, Inc. $24.5M of $41.0M · 59.7%
- Iantrek, Inc. $34.7M of $42.0M · 82.8%
-
Joyce Erony — Director, Aliso Viejo, CA
1 other raise
- Miach Orthopaedics Inc. $7.5M of $15.0M · 50.0%
-
Fouad Azzam — Director, Aliso Viejo, CA
1 other raise
- EQT Health Economics 3 Cooperatief U.A. $580K of —
- Randy Ban — Director, Aliso Viejo, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.